(NP (NP (NP-COOD (NP SRC-related/JJ proto-oncogenes/NNS) and/CC (NP transcription/NN factors/NNS)) (PP in/IN (NP primary/JJ human/JJ T/NN cells/NNS)) :/:) (NP (NP modulation/NN) (PP by/IN (NP-COOD (NP cyclosporin/NN A/NN) and/CC (NP FK506/NN))) ./.))
(S (NP-SBJ (NP Activation/NN) (PP of/IN (NP T/NN lymphocytes/NNS))) (VP induces/VBZ (NP (NP transcription/NN) (PP of/IN (NP (NP genes/NNS) (VP encoding/VBG (PP for/IN (NP lymphokines/NNS))))))) ./.)
(S (NP-SBJ-41 (NP (NP Interleukin-2/NN) (PRN -LRB-/-LRB- (NP IL-2/NN) -RRB-/-RRB-)) gene/NN expression/NN) (VP is/VBZ (VP controlled/VBN (NP *-41/-NONE-) (ADVP transcriptionally/RB) (PP by/IN (NP-LGS (NP the/DT cooperative/JJ activity/NN) (PP of/IN (NP (NP specific/JJ trans-activating/JJ factors/NNS) (SBAR (WHNP-42 that/WDT) (S (NP-SBJ *T*-42/-NONE-) (VP bind/VBP (PP to/TO (NP the/DT IL-2/NN enhancer/NN))))))))))) ./.)
(S (NP-SBJ-COOD (NP (NP Cyclosporin/NN A/NN) (PRN -LRB-/-LRB- (NP CsA/NN) -RRB-/-RRB-)) and/CC (NP FK506/NN)) (VP inhibit/VBP (NP (NP the/DT production/NN) (PP of/IN (NP IL-2/NN)) (PP in/IN (NP T/NN lymphocytes/NNS)) (PP at/IN (NP (NP the/DT level/NN) (PP of/IN (NP gene/NN transcription/NN)))))) ./.)
(S (NP-SBJ-43 (NP (NP A/DT member/NN) (PP of/IN (NP the/DT src/NN gene/NN family/NN))) ,/, (NP (NP the/DT lymphocyte-specific/JJ protein/NN tyrosine/NN kinase/NN) ,/, (NP p56lck/NN) ,/,)) (VP has/VBZ (VP been/VBN (VP implicated/VBN (NP *-43/-NONE-) (PP in/IN (NP IL-2/NN production/NN))))) ./.)
(S (NP-SBJ-44 CsA/NN) (VP was/VBD (VP found/VBN (S (NP-SBJ *-44/-NONE-) (VP not/RB to/TO (VP inhibit/VB (NP-COOD (NP lck/NN gene/NN expression/NN) ,/, nor/CC (NP (NP the/DT activity/NN) (PP of/IN (NP the/DT lck/NN gene/NN product/NN))))))))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ-COOD (NP CsA/NN) and/CC (NP FK506/NN)) (VP inhibit/VBP (NP (NP the/DT appearance/NN) (PP of/IN (NP (NP DNA/NN binding/NN activity/NN) (PP of/IN (NP (NP factors/NNS) (SBAR (WHNP-45 that/WDT) (S (NP-SBJ *T*-45/-NONE-) (VP bind/VBP (PP to/TO (NP the/DT (NP-COOD (NP NF-AT/NN) and/CC (NP AP-1/NN)) sites/NNS)) (PP in/IN (NP the/DT IL-2/NN enhancer/NN))))))))))) ./.)
(S (SBAR-ADV Since/IN (S (NP-SBJ-46 (NP the/DT induction/NN) (PP of/IN (NP-COOD (NP NF-AT/NN) and/CC (NP AP-1/NN)))) (VP is/VBZ (VP induced/VBN (NP *-46/-NONE-) (PP by/IN (NP-LGS (NP the/DT same/JJ stimuli/NNS) (SBAR (WHNP-47 that/WDT) (S (NP-SBJ *T*-47/-NONE-) (VP stimulate/VBP (NP IL-2/NN production/NN)))))))))) ,/, (NP-SBJ these/DT results/NNS) (VP indicate/VBP (SBAR that/IN (S (NP-SBJ-48 (NP the/DT immunosuppressant/JJ action/NN) (PP of/IN (NP-COOD (NP CsA/NN) and/CC (NP FK506/NN)))) (VP is/VBZ (VP exerted/VBN (NP *-48/-NONE-) (PP at/IN (NP (NP the/DT level/NN) (PP of/IN (NP these/DT trans-activating/JJ factors/NNS))))))))) ./.)
